Detalles de la búsqueda
1.
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
Proc Natl Acad Sci U S A
; 120(49): e2312261120, 2023 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011568
2.
Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance.
Eur Radiol
; 33(6): 3792-3800, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749370
3.
Urinary symptoms and prostate cancer-the misconception that may be preventing earlier presentation and better survival outcomes.
BMC Med
; 20(1): 264, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35922801
4.
Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population.
BMC Cancer
; 22(1): 878, 2022 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953766
5.
Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance.
Eur Radiol
; 32(1): 680-689, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255161
6.
Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.
Br J Cancer
; 124(5): 896-900, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33288843
7.
MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance.
Eur Radiol
; 31(5): 2696-2705, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33196886
8.
Rationalising the use of investigation for urinary tract infections: Analysis of 700 patients and proposal for a diagnostic algorithm.
Int J Clin Pract
; 75(5): e13977, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33369808
9.
Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study.
BMC Med
; 18(1): 95, 2020 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299423
10.
Removing rician bias in diffusional kurtosis of the prostate using real-data reconstruction.
Magn Reson Med
; 83(6): 2243-2252, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31737935
11.
Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma.
BJU Int
; 125(1): 56-63, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31206987
12.
Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Eur Radiol
; 30(7): 4039-4049, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166495
13.
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
PLoS Genet
; 13(9): e1007001, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945760
14.
Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
PLoS Med
; 16(3): e1002758, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30860997
15.
Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model.
Br J Cancer
; 121(8): 715-718, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31523057
16.
Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.
BJU Int
; 124(5): 758-767, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31063245
17.
Implementation and yield of upfront genomic profiling in a clinical prostate cancer diagnostic pathway.
BJU Int
; 132(5): 499-501, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37431085
18.
Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.
BJU Int
; 122(4): 599-609, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603575
19.
Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer.
BJU Int
; 122(1): 59-65, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438586
20.
Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population.
Eur Radiol
; 28(8): 3141-3150, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29222677